Nasdaq Biotechnology Index Closes Up 2.2%, Hits Fifth Consecutive Record High on June 26

On Friday, June 26, the Nasdaq Biotechnology Index closed up 2.2%, reaching its fifth consecutive closing record high. Leading gainers included Pyxis Oncology at +24.22%, followed by Humacyte, ATAI Beckley, Moderna, Immunitybio Inc., GH Research, and Abcellera Biologics at gains ranging from 18.05% to 10.81%. Compass Pathways rose 9.20%. Decliners included Omauro Pharmaceuticals (OMER) down 19.17%, Mesoblast down 9.03%, and Ardelyx down 8.50%.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments